Risk factors of bronchopulmonary dysplasia in very preterm infants: a multicenter study

doi:10.3877/cma.j.issn.1673-5250.2022.04.007

Objective

To explore influencing factors of bronchopulmonary dysplasia (BPD) in very premature infants.

Methods

From 1 January to 31 December 2020, a total of 208 very premature infants who were born and treated in the Affiliated Hospital of Qingdao University, Jining No.1 People′s Hospital, Qingdao Municipal Hospital and Maternity and Child Health Care of Zaozhuang, were chosen as research subjects. According to whether BPD occurred or not, they were divided into BPD group (n=153) and non-BPD group (n=55). Then according to severity degree of BPD, very premature infants in BPD group were divided into grade Ⅰ BPD subgroup (n=31), grade Ⅱ BPD subgroup (n=17) and grade Ⅲ BPD subgroup (n=7). Clinical data of 208 very premature infants were retrospectively analyzed. Conditions at birth and of treatment, and fluid intake within 14 d after birth of very premature infants were statistically compared between BPD and non-BPD groups, and among 3 BPD subgroups. Multivariate unconditional logistic regression analysis was used to investigate the influencing factors of BPD occurence in very premature infants and grade Ⅲ BPD occurence in BPD very premature infants. This study was approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No. QYFYWZll26841). All the guardians of the infants signed the informed consents of clinical study.

Results

① The gestational age, weight, head circumference and body length at birth, and 1, 5, 10 min Apgar scores of very premature infants in BPD group were smaller, lighter, shorter, lower than those in non-BPD group; while the usage of prenatal hormones to mother, the incidence of birth asphyxia, usage of pulmonary surfactant (PS), incidence of early onset sepsis (EOS), usage time of invasive and non-invasive ventilation of very premature infants, were higher or longer than those in non-BPD group. And the above differences were statistically significant (P<0.05). ② The total fluid intake at 2, 4, 5, 7, 11, 12 d after birth, and intravenous infusion volume of parenteral fluid at 6 d, 8-14 d after birth of very premature infants in BPD group were more than those in non-BPD group; while the enteral fluid intake at 1-14 d after birth were less than those in non-BPD group. And the above differences were statistically significant (P<0.05). ③ Multivariate unconditional logistic regression analysis showed that lower 1 min Apgar score (OR=1.866, 95%CI: 1.063-3.274, P=0.030), longer duration of invasive ventilation (OR=1.834, 95%CI: 1.158-2.905, P=0.010), longer duration of non-invasive ventilation (OR=1.163, 95%CI: 1.067-1.267, P=0.001), EOS occurence (OR=0.071, 95%CI: 0.011-0.465, P=0.006) were independent risk factors of BPD occurrence in very premature infants. The larger volume of enteral fluid intake at 3, 4, 5 d after birth (OR=0.671, 0.708, 0.746; 95%CI: 0.483-0.932, 0.511-0.846, 0.583-0.955; P=0.017, 0.004, 0.020) were independent protective factors of BPD occurrence in very premature infants. ④ There were significant differences among grade Ⅰ, Ⅱ and Ⅲ BPD subgroups in gestational age at birth, prenatal hormone application to mother, birth asphyxia rate, incidence of EOS and duration of invasive mechanical ventilation, also in total fluid intake and intravenous infusion volume of parenteral fluid at 1, 2, 4, 5, 6 d after birth, and enteral fluid intake at 1 d after birth (all P<0.05). However, these 16 indicators were not independent influencing factors of grade Ⅲ BPD occurrence in BPD very premature infants.

Conclusions

The occurrence of BPD in very premature infants is the result of multiple factors. Reducing incidence of birth asphyxia and EOS, optimizing respiratory support strategies, and increasing enteral fluid intake at 3-5 d after birth, would be expected to reduce incidence of BPD in very premature infants.

Key words: Bronchopulmonary dysplasia, Fluid intake, Risk factors, Respiration, artificial, Infant, extremely premature

表1 BPD与非BPD组极早产儿一般临床资料及治疗情况比较

组别	例数	出生胎龄(周，±s)	男性[例数(%)]	BW(g，±s)	出生头围[cm，M(Q₁，Q₃)]	出生身长[cm，M(Q₁，Q₃)]	生后1 min Apgar评分[分，M(Q₁，Q₃)]	生后5 min Apgar评分[分，M(Q₁，Q₃)]
BPD组	55	29.5±1.7	32(58.2)	1 198±279	28(26，29)	37(35，40)	8(5，9)	9(7，9)
非BPD组	153	31.1±1.6	95(62.1)	1 467±283	28(29，30)	40(38，42)	9(7，10)	10(8，10)
统计量		t＝6.446	χ²＝0.209	t＝6.143	Z＝－4.445	Z＝－5.424	Z＝－3.280	Z＝－4.044
P值		<0.001	0.672	<0.001	<0.001	<0.001	0.001	<0.001
组别	例数	生后10 min Apgar评分[分，M(Q₁，Q₃)]	合并PDA[例数(%)]	小于胎龄儿[例数(%)]	剖宫产娩出[例数(%)]	多胎儿[例数(%)]	孕母胎膜早破[例数(%)]	孕母产前使用激素[例数(%)]
BPD组	55	9(9，10)	15(27.3)	8(14.6)	42(76.4)	8(14.6)	16(29.1)	31(58.5)
非BPD组	153	10(9，10)	41(26.8)	13(8.5)	116(75.8)	35(22.9)	41(26.8)	59(38.6)
统计量		Z＝－4.286	χ²＝0.005	χ²＝1.631	χ²＝0.007	χ²＝1.712	χ²＝0.107	χ²＝5.223
P值		<0.001	0.946	0.202	0.935	0.191	0.744	0.022
组别	例数	出生窒息[例数(%)]	孕母妊娠期高血压疾病[例数(%)]	孕母妊娠期糖尿病[例数(%)]	使用PS[例数(%)]	发生EOS[例数(%)]	有创机械通气时间(d，±s)	无创机械通气时间(d，±s)
BPD组	55	21(39.6)	14(26.4)	7(13.2)	35(63.6)	23(43.4)	8.89±1.21	25.1±3.7
非BPD组	153	24(15.7)	40(26.1)	34(22.2)	39(25.5)	37(24.2)	0.36±0.15	10.8±2.4
统计量		χ²＝12.076	χ²＝0.010	χ²＝2.305	χ²＝25.685	χ²＝6.130	t＝－85.743	t＝－32.580
P值		0.001	0.920	0.129	<0.001	0.013	<0.001	<0.001

表1 BPD与非BPD组极早产儿一般临床资料及治疗情况比较

组别	例数	出生胎龄(周，±s)	男性[例数(%)]	BW(g，±s)	出生头围[cm，M(Q₁，Q₃)]	出生身长[cm，M(Q₁，Q₃)]	生后1 min Apgar评分[分，M(Q₁，Q₃)]	生后5 min Apgar评分[分，M(Q₁，Q₃)]
BPD组	55	29.5±1.7	32(58.2)	1 198±279	28(26，29)	37(35，40)	8(5，9)	9(7，9)
非BPD组	153	31.1±1.6	95(62.1)	1 467±283	28(29，30)	40(38，42)	9(7，10)	10(8，10)
统计量		t＝6.446	χ²＝0.209	t＝6.143	Z＝－4.445	Z＝－5.424	Z＝－3.280	Z＝－4.044
P值		<0.001	0.672	<0.001	<0.001	<0.001	0.001	<0.001
组别	例数	生后10 min Apgar评分[分，M(Q₁，Q₃)]	合并PDA[例数(%)]	小于胎龄儿[例数(%)]	剖宫产娩出[例数(%)]	多胎儿[例数(%)]	孕母胎膜早破[例数(%)]	孕母产前使用激素[例数(%)]
BPD组	55	9(9，10)	15(27.3)	8(14.6)	42(76.4)	8(14.6)	16(29.1)	31(58.5)
非BPD组	153	10(9，10)	41(26.8)	13(8.5)	116(75.8)	35(22.9)	41(26.8)	59(38.6)
统计量		Z＝－4.286	χ²＝0.005	χ²＝1.631	χ²＝0.007	χ²＝1.712	χ²＝0.107	χ²＝5.223
P值		<0.001	0.946	0.202	0.935	0.191	0.744	0.022
组别	例数	出生窒息[例数(%)]	孕母妊娠期高血压疾病[例数(%)]	孕母妊娠期糖尿病[例数(%)]	使用PS[例数(%)]	发生EOS[例数(%)]	有创机械通气时间(d，±s)	无创机械通气时间(d，±s)
BPD组	55	21(39.6)	14(26.4)	7(13.2)	35(63.6)	23(43.4)	8.89±1.21	25.1±3.7
非BPD组	153	24(15.7)	40(26.1)	34(22.2)	39(25.5)	37(24.2)	0.36±0.15	10.8±2.4
统计量		χ²＝12.076	χ²＝0.010	χ²＝2.305	χ²＝25.685	χ²＝6.130	t＝－85.743	t＝－32.580
P值		0.001	0.920	0.129	<0.001	0.013	<0.001	<0.001

图1 BPD与非BPD组极早产儿生后14 d内液体摄入量比较(图1A：每日液体总摄入量；图1B：每日肠外液体静脉输注量；图1C：每日肠内液体摄入量)注：^a表示BPD与非BPD组比较，P<0.05。BPD为支气管肺发育不良

表2 极早产儿发生BPD的多因素非条件logistic回归分析结果^a

影响因素	B	SE	Wald值	P值	OR值	OR值95%CI
生后1 min Apgar评分	0.624	0.287	4.726	0.030	1.866	1.063~3.274
有创机械通气时间	0.607	0.235	6.686	0.010	1.834	1.158~2.905
无创机械通气时间	0.151	0.044	11.836	0.001	1.163	1.067~1.267
发生EOS	－2.644	0.959	7.608	0.006	0.071	0.011~0.465
生后第3天肠内液体摄入量	－0.400	0.168	5.670	0.017	0.671	0.483~0.932
生后第4天肠内液体摄入量	0.346	0.120	8.335	0.004	1.413	1.117~1.787
生后第5天肠内液体摄入量	－0.292	0.126	5.400	0.020	0.746	0.583~0.955
常数项	－4.618	12.563	0.135	0.713	0.010	—

表2 极早产儿发生BPD的多因素非条件logistic回归分析结果^a

影响因素	B	SE	Wald值	P值	OR值	OR值95%CI
生后1 min Apgar评分	0.624	0.287	4.726	0.030	1.866	1.063~3.274
有创机械通气时间	0.607	0.235	6.686	0.010	1.834	1.158~2.905
无创机械通气时间	0.151	0.044	11.836	0.001	1.163	1.067~1.267
发生EOS	－2.644	0.959	7.608	0.006	0.071	0.011~0.465
生后第3天肠内液体摄入量	－0.400	0.168	5.670	0.017	0.671	0.483~0.932
生后第4天肠内液体摄入量	0.346	0.120	8.335	0.004	1.413	1.117~1.787
生后第5天肠内液体摄入量	－0.292	0.126	5.400	0.020	0.746	0.583~0.955
常数项	－4.618	12.563	0.135	0.713	0.010	—

表3 3个BPD亚组极早产儿一般临床资料及治疗情况比较

组别	例数	出生胎龄(周，±s)	BW(g，±s)	出生头围(cm，±s)	出生身长(cm，±s)	Apgar评分(分，±s)
组别	例数	出生胎龄(周，±s)	BW(g，±s)	出生头围(cm，±s)	出生身长(cm，±s)	生后1 min	生后5 min	生后10 min
Ⅰ度BPD亚组	31	29.1±1.4	1 175±271	27.2±2.2	36.8±2.9	6.9±2.2	7.9±1.6	9.1±0.6
Ⅱ度BPD亚组	17	30.6±1.2	1 246±217	27.5±2.1	37.9±2.5	7.3±2.6	8.6±1.6	9.1±1.0
Ⅲ度BPD亚组	7	28.6±2.4	1 184±414	25.7±3.5	36.1±4.8	6.1±3.6	7.3±3.7	8.1±2.7
F值		7.129	0.372	1.558	1.117	0.506	1.300	1.897
P值		0.002	0.691	0.220	0.335	0.606	0.281	0.162
组别	例数	孕母产前使用激素[例数(%)]	出生窒息[例数(%)]	使用PS[例数(%)]	发生EOS[例数(%)]	有创机械通气时间(d，±s)	无创机械通气时间(d，±s)
Ⅰ度BPD亚组	31	12(38.7)	6(19.4)	21(67.7)	7(22.6)	2.5±1.2	24.1±1.4
Ⅱ度BPD亚组	17	12(70.6)	8(47.1)	9(52.9)	11(64.7)	2.6±0.5	25.7±5.0
Ⅲ度BPD亚组	7	7(100.0)	7(100.0)	5(71.4)	5(71.4)	52.7±15.3	28.1±8.2
F值		10.746	16.556	1.250	10.898	276.455	3.032
P值		0.005	<0.001	0.535	0.004	<0.001	0.057

表3 3个BPD亚组极早产儿一般临床资料及治疗情况比较

组别	例数	出生胎龄(周，±s)	BW(g，±s)	出生头围(cm，±s)	出生身长(cm，±s)	Apgar评分(分，±s)
组别	例数	出生胎龄(周，±s)	BW(g，±s)	出生头围(cm，±s)	出生身长(cm，±s)	生后1 min	生后5 min	生后10 min
Ⅰ度BPD亚组	31	29.1±1.4	1 175±271	27.2±2.2	36.8±2.9	6.9±2.2	7.9±1.6	9.1±0.6
Ⅱ度BPD亚组	17	30.6±1.2	1 246±217	27.5±2.1	37.9±2.5	7.3±2.6	8.6±1.6	9.1±1.0
Ⅲ度BPD亚组	7	28.6±2.4	1 184±414	25.7±3.5	36.1±4.8	6.1±3.6	7.3±3.7	8.1±2.7
F值		7.129	0.372	1.558	1.117	0.506	1.300	1.897
P值		0.002	0.691	0.220	0.335	0.606	0.281	0.162
组别	例数	孕母产前使用激素[例数(%)]	出生窒息[例数(%)]	使用PS[例数(%)]	发生EOS[例数(%)]	有创机械通气时间(d，±s)	无创机械通气时间(d，±s)
Ⅰ度BPD亚组	31	12(38.7)	6(19.4)	21(67.7)	7(22.6)	2.5±1.2	24.1±1.4
Ⅱ度BPD亚组	17	12(70.6)	8(47.1)	9(52.9)	11(64.7)	2.6±0.5	25.7±5.0
Ⅲ度BPD亚组	7	7(100.0)	7(100.0)	5(71.4)	5(71.4)	52.7±15.3	28.1±8.2
F值		10.746	16.556	1.250	10.898	276.455	3.032
P值		0.005	<0.001	0.535	0.004	<0.001	0.057

图2 3个BPD亚组极早产儿生后14 d内液体摄入量比较(图2A：每日液体总摄入量；图2B：每日肠外液体静脉输注量；图2C：每日肠内液体摄入量)注：^a表示3个BPD亚组比较的P<0.05。BPD为支气管肺发育不良

[1]	Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375: n1974. DOI: 10.1136/bmj.n1974.
[2]	Mowitz ME, Gao W, Sipsma H, et al. Long-term burden of respiratory complications associated with extreme prematurity: an analysis of US Medicaid claims[J]. Pediatr Neonatol, 2022: S1875-9572(22)00118-8. DOI: 10.1016/j.pedneo.2022.05.007.
[3]	Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop[J]. J Pediatr, 2018, 197: 300-308. DOI: 10.1016/j.jpeds.2018.01.043.
[4]	山东省多中心NICU早产儿入院低体温质量改进临床研究协作组. 基于证据的质量改进方法降低极低出生体重儿入院低体温发生率的多中心研究方案[J]. 中国循证儿科杂志，2019, 14(2): 139-142. DOI: 10.3969/j.issn.1673-5501.2019.02.012.
[5]	Sriram S, Schreiber MD, Msall ME, et al. Cognitive development and quality of life associated with bpd in 10-year-olds born preterm[J]. Pediatrics, 2018, 141(6): e20172719. DOI: 10.1542/peds.2017-2719.
[6]	Shukla VV, Ambalavanan N. Recent advances in bronchopulmonary dysplasia[J]. Indian J Pediatr, 2021, 88(7): 690-695. DOI: 10.1007/s12098-021-03766-w.
[7]	Malikiwi AI, Lee YM, Davies-Tuck M, et al. Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation[J]. Early Hum Dev, 2019, 131: 29-35. DOI: 10.1016/j.earlhumdev.2019.02.005.
[8]	吴怡玲，芦惠，张志群. 营养与支气管肺发育不良关系研究进展[J]. 中华新生儿科杂志(中英文), 2020, 35(2): 148-152. DOI: 10.3760/cma.j.issn.2096-2932.2020.02.019.
[9]	Muehlbacher T, Bassler D, Bryant MB. Evidence for the management of bronchopulmonary dysplasia in very preterm infants[J]. Children (Basel), 2021, 8(4): 298. DOI: 10.3390/children8040298.
[10]	Rocha G, Guimarães H, Pereira-da-Silva L. The role of nutrition in the prevention and management of bronchopulmonary dysplasia: a literature review and clinical approach[J]. Int J Environ Res Public Health, 2021, 18(12): 6245. DOI: 10.3390/ijerph18126245.
[11]	卢庆晖，东方，张松青，等. 支气管肺发育不良极低出生体重早产儿生后4天内液体摄入量和中心静脉压特点分析[J]. 中华新生儿科杂志(中英文), 2020, 35(2): 123-126. DOI: 10.3760/cma.j.issn.2096-2932.2020.02.011.
[12]	Barrington KJ, Fortin-Pellerin E, Pennaforte T. Fluid restriction for treatment of preterm infants with chronic lung disease[J]. Cochrane Database Syst Rev, 2017, 2(2): CD005389. DOI: 10.1002/14651858.CD005389.pub2.
[13]	Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants[J]. Cochrane Database Syst Rev, 2014, 2014(12): CD000503. DOI: 10.1002/14651858.CD000503.pub3.
[14]	Al-Jebawi Y, Agarwal N, Groh Wargo S, et al. Low caloric intake and high fluid intake during the first week of life are associated with the severity of bronchopulmonary dysplasia in extremely low birth weight infants[J]. J Neonatal Perinatal Med, 2020, 13(2): 207-214. DOI: 10.3233/NPM-190267.
[15]	Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants[J]. J Pediatr, 2005, 147(6): 786-790. DOI: 10.1016/j.jpeds.2005.06.039.
[16]	Jochum F, Moltu SJ, Senterre T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: fluid and electrolytes[J]. Clin Nutr, 2018, 37(6 Pt B): 2344-2353. DOI: 10.1016/j.clnu.2018.06.948.
[17]	Eibensteiner F, Laml-Wallner G, Thanhaeuser M, et al. ELBW infants receive inadvertent sodium load above the recommended intake[J]. Pediatr Res, 2020, 88(3): 412-420. DOI: 10.1038/s41390-020-0867-9.
[18]	Kim SB, Lee JH, Lee J, et al. The efficacy and safety of montelukast sodium in the prevention of bronchopulmonary dysplasia[J]. Korean J Pediatr, 2015, 58(9): 347-353. DOI: 10.3345/kjp.2015.58.9.347.
[19]	Soullane S, Patel S, Claveau M, et al. Fluid status in the first 10 days of life and death/bronchopulmonary dysplasia among preterm infants[J]. Pediatr Res, 2021, 90(2): 353-358. DOI: 10.1038/s41390-021-01485-8.

[1]	Jinli Zhang, Maomao Xi, Zhigang Chu, Xiagang Luan, Nuo Chen, Deyun Wang, Weiguo Xie. Analysis of risk factors of early acute kidney injury in patients with massive burn injuries[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(04): 282-287.
[2]	Hongchu Huang, Meirong Huang, Lihong Wen. Risk factor analysis and risk prediction model of granulocytopenia infection after chemotherapy in patients with hematological malignancies[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(05): 285-292.
[3]	Wenbin Luo, Wei Han. Analysis of risk factors related to moderate to severe myelosuppression in patients with pancreatic cancer after first chemotherapy and construction of prediction model[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(05): 357-362.
[4]	Bin He, Jinfeng Ma. Risk factors for splenic hilar lymph node metastasis in gastric cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 694-699.
[5]	Kai Lin, Yong Pan, Gaoping Zhao, Chun Yang. Analysis of risk factors and prevention strategy of incisional hernia after stoma reduction surgery[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 634-638.
[6]	Chuang Yang, Xue Ma. Analysis of risk factors for postoperative infection of abdominal wall hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 693-696.
[7]	Yan Zhou, Ying Li, Xiaobing Zhou, Fahui Cheng, Hengzheng He. Efficacy of different types of mesh combined with Nissen fundoplication for repairing hiatal hernia and potential risk factors for recurrence[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 528-533.
[8]	Jinhong Zhou, Jianjie Wang, Xiaojun Xie. Analysis of incidence and risk factors of postoperative urinary retention after TAPP[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(04): 390-395.
[9]	Weiwei Zhang, Qi Chen, Heyu Weng, Liang Huang. Preliminary study on prediction of lymph node metastasis of T1 colorectal cancer by random forest model[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 389-393.
[10]	Nan Si, Hongtao Sun. Research progress on risk factors of renal dysfunction after traumatic brain injury[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2024, 14(05): 300-305.
[11]	Huiying Chen, Minshan Qiu, Hanquan Shao. Construction and application effect of risk factor model for intestinal mucosal barrier function damage induced by sepsis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 448-452.
[12]	Xiangqing Qin, Chen Zhu, Haiyin Zhang. Construction of a normogram model for predicting the risk of esophageal and gastric varices bleeding in cirrhosis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 330-335.
[13]	Shirui Yan, Hui Xiong. Identification of risk factors for acute kidney injury in patients with infective endocarditis and prediction of death risk in such patients with acute kidney injury[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 618-624.
[14]	Wenzhe Li, Yi Wang, Jian Cui, Qihang Zheng, Jingyan Wang, Xiangyou Yu. Critically ill patients with acute renal dysfunction in Xinjiang Uygur Autonomous Region：A crosssection study[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2024, 10(05): 269-276.
[15]	Zhichao Liu, Fengyun Hu, Chunli Wen. Risk factors and geographical correlation of stroke in Shanxi Province[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 424-433.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export